Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.
about
Antifungal Prophylaxis in Immunocompromised PatientsAntifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study.Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT.Mucormycete infection or colonisation: experience of an Australian tertiary referral centre.Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes.Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin - case study and brief literature reviewUse of computed tomography abdomen and pelvis for investigation of febrile neutropenia in adult haematology patients.Allogeneic hematopoietic cell transplantation without fluconazole and fluoroquinolone prophylaxis.Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.Invasive fungal infections in ALL: a new 'growth' area.Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.Fungal infections in patients with inflammatory bowel disease: a systematic review.Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection.Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.Timing Determination of Invasive Fungal Infection Prophylaxis According to Immune Function in HSCT Patients.Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantationInvasive Fungal Infections in Patients with Chronic Lymphoproliferative Disorders in the Era of Target Drugs
P2860
Q28074168-03D66C92-972F-4ED8-8F91-DA6B2F9D527EQ37280740-B8FF5982-537B-4293-856C-24E1A9A36392Q38284447-6B2890D0-6A87-4F53-BF37-DF998B73BD7FQ38620631-C9425A25-B119-4D2C-BE26-206E85CF58B5Q38690098-7BFBB439-BED0-4709-9765-02FA93D4DA8FQ38726670-90D75694-2B39-4719-9DE6-CA3E79F5998EQ38937601-89D15FE0-1727-4DC4-B618-31F646C77023Q38965488-5FD03D28-1A49-4328-B85A-817F8097152EQ39171248-6DE904EC-3ECF-4352-B87F-2DA8C1A34928Q39196770-7FE08A85-7C57-4196-9994-1D063DE54D73Q39247468-D673101A-9594-486D-984E-3239022441AFQ39416431-BA0FC6AF-EEBB-418A-839B-44088117FAE3Q40081185-9D143B9D-D83F-4E75-9F0C-675A7AA3750AQ40400784-56E1311C-8262-4F23-A11E-73154D1BCE4AQ40515140-0D312528-C4A8-49B9-9714-0EE251106725Q40577292-D4754356-134F-4539-A816-DC8C60438FB2Q40695580-6A80EE4D-6CA4-4A2B-8D38-B0925112E203Q47205373-F052E1B6-9F22-4382-92CB-095AD34613E1Q49906677-18D414D9-C602-4F49-86A3-73EABA8BB115Q52777337-BF0C176F-3921-42E8-B3FE-B60D168ADE75Q53053165-2A95E752-EDF1-464A-A9BA-E3FD156C1E48Q53393992-558318B4-6E41-4EAD-9516-040488AF843BQ54253884-3FEB6148-EF68-42DF-86C2-E8275C576DCBQ57482863-2293D0A3-E667-4D04-9395-E4FD605F5ACDQ58701117-827F4CC3-FFE4-49B0-AE02-1D763AB34038
P2860
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Consensus guidelines for antif ...... em cell transplantation, 2014.
@en
type
label
Consensus guidelines for antif ...... em cell transplantation, 2014.
@en
prefLabel
Consensus guidelines for antif ...... em cell transplantation, 2014.
@en
P2093
P2860
P50
P356
P1476
Consensus guidelines for antif ...... em cell transplantation, 2014.
@en
P2093
C K Yannakou
C O Morrissey
S J van Hal
S T Milliken
P2860
P304
P356
10.1111/IMJ.12595
P577
2014-12-01T00:00:00Z